Pediatric and adult forms of type I autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition

Hepatology

Volumn 30, Issue 6, 1999, Pages 1374-1380

  Pando, Marcelo ^a   Larriba, Julian ^a   Fernandez, Gabriela C ^a   Fainboim, Hugo ^b   Ciocca, Mirta ^c   Ramonet, Margarita ^d   Badia, Isabel ^e   Daruich, Jorge ^a   Findor, Jorge ^a   Tanno, Hugo ^f   Canero Velasco, Cristina ^g   Fainboim, Leonardo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^e HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^f Facultad de Medicina   (Argentina)

^g Hospital de Ninos de San Justo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ANALYTIC METHOD; ARGENTINA; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; ETHNIC GROUP; FEMALE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL;

EID: 0032722786     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300611     Document Type: Article

References (27)

1. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
2. Mackay IR. Immunological aspects of chronic active hepatitis. HEPATOLOGY 1983;3:724-728.
3. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. HEPATOLOGY 1993;18:998-1005.
4. Donaldson P, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens HLA-DR4 and AI-B8-DR3 are independent risk factors. HEPATOLOGY 1991;13:701-706.
5. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. HEPATOLOGY 1997;25:317-323.
6. Fainboim L, Pando M, Capucchio M, Reyes B, Galoppo C, Gorodezky C, Fainboim H, et al. HLA and autoimmune hepatitis. In: Charron D (ed). HLA: Genetic Diversity of HLA Functional and Medical Implication. Vol. 1. Paris: Medical and Scientific International Publisher 1997:418-422.
7. Fainboim L, Marcos Y, Pando M, Capucchio M, Reyes GB, Galoppo C, Badia I, et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (HLA-DRB1*1301) haplotype. Hum Immunol 1994;41:146-150.
8. Marcos Y, Fainboim HA, Capucchio M, Findor J, Daruich J, Reyes B, Pando M, et al. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis. HEPATOLOGY 1994;19:1371-1374.
9. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, Mizuki N, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992;103:1041-1047.
10. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-1832.
11. Fernandez-Vina MA, Binon JD. Proceedings of the Twelfth International Histocompatibility Workshop and Conference, Charron D (ed). Vol. 1. Paris: Medical and Scientific International Publisher 1997:584-595.
12. Krausa P, Moses JH, Bodmer WF, Bodmer JG, Browning M. HLA-A locus alleles identified by sequence specific PCR. Lancet 1993;341:121-122.
13. Bengtsson BO, Thompson G. Measuring the strength of associations between HLA antigens and diseases. Tissue Antigens 1981;18:356-363.
14. Svejgaard A, Ryder L. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27.
15. Payami H, Joe S, Farid NR, Srenszky V, Chan SH, Yeo PPB, Cheah JS, et al. Relative predispositional effects (RPEs) of merkers alleles with disease: HLA-DR alleles and Grave's disease. Am J Hum Genet 1989;45:541-546.
16. Brown JH, Strettell MD, Thomson LJ, Donaldson PT, Bunce M, O'Neill CM, Williams R. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33-39.
17. Stern LJ, Ota M, Seki T, Kiyosawa K, Furuta S, Hino K, Kondo T, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221.
18. Strettell MD, Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112:2028-2035.
19. Ota M, Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Stem LJ, Urban RG, et al. A possible association between basic amino acids of position 13 of HLA-DRB1 chains and autoimmune hepatitis. Immunogenetics 1992;36:49-55.
20. Newton-Nash D, Eckels D. J Immunol 1993;150:1813-1821.
21. Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 1991;147:1292-1298.
22. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998;113:244-251.
23. Langó-Warensjo A, Cardell K, Lindblom B. Haplotypes comprising subtypes of the HLA-DQB1*06 allele direct the antibody response after immunization with hepatitis B surface antigen. Tissue Antigens 1998;52:374-380.
24. Hill A, Allsopp C, Kwiatkowski D, Anstey N, Twumasi P, Rowe P, Bennett S, et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
25. Gonzales J, Fay O, Can̄ero Velazco M, Fernández E, Carchio E, Moreiro R, Weller C, et al. Infeccion por virus de hepatitis A (HAV) en ninos en Argentina, ensayo piloto. Acta Gastroent Latinoamer 1997;27:331-334.
26. Rahaman SM, Chira P, Koff RS. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol 1994;89:106-108.
27. Vento S, Garofano T, DiPerri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 insusceptible individuals. Lancet 1991;337:1183-1187.